title: Effectiveness of rivastigmine in Alzheimer's disease. Guidelines do not ignore clinically relevant end points.
authors.forename: J G
authors.initials: JG
authors.lastname: Storosum
authors.forename: B J
authors.initials: BJ
authors.lastname: van Zwieten-Boot
authors.forename: A J
authors.initials: AJ
authors.lastname: Elferink
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy*; D002219:Carbamates / Q000627:therapeutic use*; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D006801:Humans; D048448:Phenylcarbamates; D017410:Practice Guidelines as Topic; D000068836:Rivastigmine
chemical_list: D002219:Carbamates; D002800:Cholinesterase Inhibitors; D048448:Phenylcarbamates; D000068836:Rivastigmine